Our mission is to unlock the science of longevity and beyond to transform the way we live. We're driven by a deep sense of purpose and urgency to discover new treatments, find cures, and make a real difference in the lives of people affected by neurological and neurodegenerative disorders, and advanced liver disease.
We believe our flagship product, bezisterim (NE3107), represents a monumental leap in this direction. A unique molecule that targets chronic low-grade inflammation throughout the body, which has been implicated as the main driver of many of the diseases of aging such as Alzheimer’s disease and Parkinson’s disease.
Through our relentless pursuit of knowledge, innovative spirit, and unwavering dedication, we are redefining the boundaries of human longevity.
Leadership Team
Cuong Do
President &
Chief Executive Officer
Dr. Joseph Palumbo
Executive Vice President, R&D
and Chief Medical Officer
Wendy Kim, CPA
Chief Financial Officer
Clarence Ahlem
Senior Vice President,
Operations
Penelope Markham, PhD
Senior Vice President
Liver Disease & Long
COVID Programs
Chris Reading, PhD
Senior Vice President,
Alzheimer's disease
Program
David Morse, PhD
Chief Regulatory Officer and Senior Vice President
